Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
|
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [1] The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma
    Couch, George
    Redman, James E.
    Wernisch, Lorenz
    Newton, Richard
    Malhotra, Shalini
    Dawsey, Sanford M.
    Lao-Sirieix, Pierre
    Fitzgerald, Rebecca C.
    CANCER PREVENTION RESEARCH, 2016, 9 (07) : 558 - 566
  • [2] Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
    Ibuki, Yuta
    Hamai, Yoichi
    Okada, Morihito
    Tahara, Hidetoshi
    CANCER SCIENCE, 2021, 112 : 871 - 871
  • [3] Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
    Ibuki, Yuta
    Nishiyama, Yukie
    Tsutani, Yasuhiro
    Emi, Manabu
    Hamai, Yoichi
    Okada, Morihito
    Tahara, Hidetoshi
    PLOS ONE, 2020, 15 (04):
  • [4] Biomarkers for Early Detection of Esophageal Squamous Cell Dysplasia and Carcinoma
    Redman, James E.
    Newton, Richard
    Malhotra, Shalini
    Dawsey, Sanford M.
    Wernisch, Lorenz
    Lao-Sirieix, Pierre
    Fitzgerald, Rebecca
    GASTROENTEROLOGY, 2014, 146 (05) : S96 - S96
  • [5] Identification of candidate plasma miRNA biomarkers for the diagnosis of head and neck squamous cell carcinoma
    Liu, Weixing
    Liu, Yue
    Li, Pei
    Chen, Jia
    Liu, Jiamin
    Shi, Zhi
    Liu, Hui
    Ye, Jin
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [6] Identification of novel biomarkers for lymph node metastasis of esophageal squamous cell carcinoma
    Luo, Xiaoqi
    Zhang, Shufan
    Yang, Manqiu
    Chen, Shaomu
    Huang, Moli
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 71 - 71
  • [7] Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update
    Liu, Fen
    Tian, Tian
    Xia, Li-Li
    Ding, Yuanjie
    Cormier, Robert T.
    He, Yan
    DISEASES OF THE ESOPHAGUS, 2017, 30 (02)
  • [8] New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma
    Xu, Shu-Yong
    Liu, Zan
    Ma, Wen-Jing
    Sheyhidin, Ilyar
    Zheng, Shu-Tao
    Lu, Xiao-Mei
    BIOMARKERS, 2009, 14 (05) : 340 - 346
  • [9] Diagnosis and therapy of esophageal squamous cell dysplasia and early esophageal squamous cell cancer
    Subramanian, Charumathi Raghu
    Triadafilopoulos, George
    GASTROENTEROLOGY REPORT, 2017, 5 (04): : 247 - 257
  • [10] Identification of novel biomarkers for lung squamous cell carcinoma
    Ranjitha Guttapadu
    Teesta Katte
    Deepak Sayeeram
    Saloni Bhatia
    Anika Rachel Abraham
    Kiran Rajeev
    Anish Raju R. Amara
    Sharadhi Siri
    Kavitha Bommana
    Avinash Arvind Rasalkar
    Rajyalakshmi Malempati
    Mohammed S. Mustak
    Prathibha Narayanan
    S. Divijendra Natha Reddy
    3 Biotech, 2023, 13